Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
74 studies found for:    "Patent ductus arteriosus"
Show Display Options
Rank Status Study
1 Recruiting Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Conditions: Patent Ductus Arteriosus;   Surgery;   Necrotizing Enterocolitis;   Intestinal Perforation
Interventions: Other: pharmacologic treatment of the PDA;   Other: no pharmacologic treatment of the PDA
2 Unknown  Treating the Resistant Patent Ductus Arteriosus (PDA)
Condition: Patent Ductus Arteriosus
Interventions: Drug: Indomethacin;   Drug: Pentoxifylline
3 Completed Closure of Patent Ductus Arteriosus With Indomethacin or Ibuprofen in Extreme Low Birth Weight Infants
Condition: Patent Ductus Arteriosus
Intervention: Drug: Ibuprofen
4 Recruiting Early Ibuprofen Treatment of Patent Ductus Arteriosus (PDA) in Premature Infants (TRIOCAPI)
Condition: Patent Ductus Arteriosus
Interventions: Drug: Ibuprofen;   Drug: Placebo
5 Completed Echocardiographically Guided Versus Standard Ibuprofen Treatment for Patent Ductus Arteriosus
Condition: Patent Ductus Arteriosus
Interventions: Drug: Ibuprofen EchoG;   Drug: Standard ibuprofen treatment
6 Completed Influence of Treatment for Patent Ductus Arteriosus on Cerebral Oxygenation in Preterm Infants
Conditions: Prematurity of Fetus;   Patent Ductus Arteriosus
Interventions: Drug: Indomethacin;   Procedure: Surgical Ligation;   Drug: Ibuprofen
7 Terminated An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants
Condition: Patent Ductus Arteriosus
Intervention: Drug: Indomethacin
8 Completed Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus
Condition: Patent Ductus Arteriosus
Intervention: Drug: indomethacin (two different dosing regimens)
9 Not yet recruiting Adding Paracetamol to Ibuprofen for Treatment of Patent Ductus Arteriosus in Preterm Infants
Condition: Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants
Interventions: Drug: Paracetamol;   Drug: Placebo
10 Unknown  Paracetamol and Patent Ductus Arteriosus (PDA)
Condition: Patent Ductus Arteriosus
Interventions: Drug: Paracetamol;   Drug: NSAID;   Drug: D5W
11 Completed Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants
Condition: Patent Ductus Arteriosus
Intervention:
12 Terminated
Has Results
Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure
Conditions: Patent Ductus Arteriosus;   Prematurity
Intervention: Drug: Ibuprofen
13 Completed Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus
Condition: Patent Ductus Arteriosus
Intervention: Device: Occlutech PDA occluder
14 Not yet recruiting International Experience in Timing And Choices for Ductal Closure in Patent Ductus Arteriosus:INTERPDA Trial
Condition: Patent Ductus Arteriosus
Intervention: Device: Echocardiography
15 Completed Comparative Study of Efficacy and Safety of Oral Ibuprofen and Intravenous Ibuprofen in Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
Condition: Patent Ductus Arteriosus
Interventions: Drug: oral ibuprofen;   Drug: intravenous ibuprofen
16 Completed Nitric Oxide, Endothelin-1, and the Patency of Ductus Arteriosus in Preterm Infants
Condition: Patent Ductus Arteriosus
Intervention:
17 Completed High-dose Ibuprofen for Patent Ductus Arteriosus (PDA) in Preterm Infant
Condition: Ductus Arteriosus, Patent
Intervention: Drug: Ibuprofen
18 Withdrawn Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies
Conditions: Ductus Arteriosus, Patent;   Very Low Birth Weight Infants
Interventions: Drug: Ibuprofen;   Drug: Indomethacin
19 Completed Safety and Efficacy of Ibuprofen in Term Newborns With Patent Ductus Arteriosus (PDA)
Condition: Patent Ductus Arteriosus
Intervention: Drug: Oral Ibuprofen
20 Completed
Has Results
Closure Of Patent Ductus Arteriosus With the AMPLATZER Duct Occluder the AMPLATZER® Duct Occluder
Condition: Patent Ductus Arteriosus (PDA)
Interventions: Device: Device closure with AMPLATZER Duct Occluder;   Other: Objective Performance Criteria

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years